ADRM1 and ovarian cancer: To elucidate whether RA475 binds to RPN13, we used Up284B as a probe and performed the labeling assay after treating ovarian cancer cell lysates (ES2 and SKOV3) in the presence of titrated doses of RA475 (unlabeled).